Arrowhead Research Corp.

Sector: Commercial Physical And Biological Research Region: CA, United States

Exchange/Ticker: Nasdaq: ARWR

Company Description

Arrowhead Research Corp. is a clinical stage nanomedicine company developing innovative therapies at the interface of biology and nanoengineering. It focuses on the preclinical and clinical development of therapeutics, in treating cancer and obesity, as well as healing wounded or diseased tissue. The company owns and operates two major subsidiaries: Calando Pharmaceuticals and Ablaris Therapeutics. Its main products include CALAA-01, an oncology drug and Adipotide, an anti-obesity peptide, which targets and kills the blood vessels that feed white adipose tissue. The company also delivers platforms, such as Dynamic Polyconjugate, Liposomal Nanoparticle, and RONDEL, which support preclinical and clinical candidates. The company was founded by R. Bruce Stewart in 1989 and is headquartered in Pasadena, CA.

Similar to: Exelixis, Inc., Advanced Cell Technology, Inc., Medivir AB

Featured Company

Orezone Gold Corp.

Ottawa, ON, CA

Orezone Gold Corporation (ORE: TSX) is a Canadian exploration and development company that is rapidly expanding a 4.84 million ounce… Learn more →